Intracellular glutathione deficiency is associated with enhanced nuclear factor-κB activation in older noninsulin dependent diabetic patients

References

• Bayness J.W., Thorpe S.R. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 1999; 48: 1–9
   PubMedGoogle Scholar
• Reed D.J. Glutathione: toxicological implications. Annu. Rev. Pharmacol. Toxicol. 1990; 30: 603–631
   PubMed Web of Science ®Google Scholar
• De la Asunción J.G., Millán A., Pla R., Bruseghini L., Esteras A., Pallardo F.V., Sastre J., Viña J. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J. 1996; 10: 333–338
   PubMed Web of Science ®Google Scholar
• Sastre J., Pallardo F.V., de la Asunción G.J., Viña J. Mitochondria, oxidative stress and aging. Free Radic. Res. 2000; 32: 189–198
   PubMed Web of Science ®Google Scholar
• Cadenas E., Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 2000; 29: 222–230
   PubMed Web of Science ®Google Scholar
• Michelet F., Gueguen R., Leroy P., Wellman M., Nicolas A., Siest G. Blood and plasma glutatwone measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin. Chem. 1995; 41: 1509–1517
   PubMed Web of Science ®Google Scholar
• Garcia-Arumí E., Andreu A.L., López-Hellin J., Schwartz S. Effect of oxidative stress on lymphocytes from elderly subjects. Clin. Sci. 1998; 94: 447–452
   Google Scholar
• Sohal R.S., Weindruch R. Oxidative stress, caloric restriction, and ageing. Science 1996; 219: 59–63
   Google Scholar
• Murakami K., Kondo T., Ohtsuku Y., Fujiwara Y., Shimada M., Kawakami Y. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 1989; 38: 753–758
   PubMed Web of Science ®Google Scholar
• Yoshida K., Hiroskawa J., Tagami S., Urata Y., Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and eflux. Diabetologia 1995; 38: 201–210
   PubMed Web of Science ®Google Scholar
• Samiec P.S., Drews-Botsch C., Flago E.W., Kurtz J.C., Sternberg P., Jr, Reed R.L., Jones D.P. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic. Biol. Med. 1998; 24: 699–704
   PubMed Web of Science ®Google Scholar
• Seghieri G., Di Simplicio P., De Giorgio L.A., Anichini R., Alberti L., Franconi F. Relationship between metabolic glycaemic control and platelet content of glutathione and its related enzymes in insulin-dependent diabetes mellitus. Clin. Chim. Acta 2000; 299: 109–117
   PubMedGoogle Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809
   PubMed Web of Science ®Google Scholar
• Dröge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.-P., Roth S., Gmünder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 1994; 8: 1131–1138
   PubMed Web of Science ®Google Scholar
• Staal F.J.T., Roederer M., Herzenberg L.A., Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci., USA 1990; 87: 9943–9947
   PubMed Web of Science ®Google Scholar
• Pickup J.C., Mattock M.B., Chusney G.D., Burt D. NIDDM as disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286–1292
   PubMed Web of Science ®Google Scholar
• Arnalich F., Hemanz A., López-Maderuelo D., Peña J.M., Camacho J., Madero R., Vázquez J.J., Montiel C. Enhanced acute-phase response and oxidative stress in older adults with type II diabetes. Horm. Metab. Res. 2000; 32: 407–412
   PubMedGoogle Scholar
• Barnes P.J., Karin M. Nuclear Factor-κB- a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997; 336: 1066–1071
   PubMed Web of Science ®Google Scholar
• Collins T., Cybulsky M.I. NF-κB: pivotal mediator or innocent bystander in atherogenesis?. J. Clin. Investig. 2001; 107: 255–264
   PubMed Web of Science ®Google Scholar
• Hernanz A., Fernández-Vivancos E., Montiel C., Vázquez J.J., Arnalich F. Changes in the intracellular homocysteine and glutathione content associated with aging. Life Sci. 2000; 67: 1317–1324
   PubMed Web of Science ®Google Scholar
• Pieper G.M., Riaz-ul-Haq. Activation of Nuclear Factor-(B in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J. Cardiovasc. Pharmacol. 1997; 30: 528–532
   PubMed Web of Science ®Google Scholar
• Bierhaus A., Chevton S., Chevton M., Hoffmann M., Quehenberger P., Illner T., Luther T., Berentshtein E., Tritschler H., Muller M., Wahl P., Ziegler R., Nawroth P.P. Advanced glycation end product-induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells. Diabetes 1997; 46: 1481–1490
   PubMed Web of Science ®Google Scholar
• Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257–267
   PubMed Web of Science ®Google Scholar
• The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183–1197
   PubMed Web of Science ®Google Scholar
• Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41
   PubMed Web of Science ®Google Scholar
• Griesmacher A., Kindhausser M., Andert S.E., Schreiner W., Toma C., Knoebl P., Pietschmann P., Prager R., Schnack C., Schernthanert G., Mueller M.M. Enhanced serum levels of thiobarbituric- acid-reactive substances in diabetes mellitus. Am. J. Med. 1996; 98: 469–475
   Google Scholar
• Lee B.L., Chua H.Y., Ong C.N. High-performance liquid chromatographic method for routine determination of vitamin A and E, and β-carotene in plasma. J. Chromatogr. 1992; 581: 41–47
   PubMed Web of Science ®Google Scholar
• te Poele-Pothoff M.T., van der Berg M., Franken D.G., Boers G.H., Jakobs C., deKroon I.F., Eskes T.K., Trijbels J.M., Blom H.J. Three different methods for the determination of total homocysteine in plasma. Annal. Clin. Biochem. 1995; 32: 218–220
   PubMedGoogle Scholar
• Montaner S., Ramos A., Perona R., Esteve P., Camero A., Lacal J.C. Overexpression of PKC in NIH 3T3 cells does not induce cell transformation nor tumorogenicity and does not, alter NF-κB activity. Oncogene 1995; 10: 2213–2220
   PubMedGoogle Scholar
• Arnalich F., Garcia-Palomero E., López J., Jiménez M., Madero R., Renart J., Vázquez J.J., Montiel C. Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis. Infec. Immun. 2000; 68: 1942–1945
   PubMed Web of Science ®Google Scholar
• Zabel U., Schreck R., Baeuerle P.A. D.N.A. binding of purified transcription factor NF-κB affinity, specificity, Zn2+ dependence, and differential half-site recognition. J. Biologic. Chem. 1991; 266: 252–260
   PubMed Web of Science ®Google Scholar
• Hoffmann M.A., Schiekofer S., Kanitz M., Klevesath M.S., Joswig M., Lee V., Morcos M., Trischler H., Ziegler R., Wahl P., Bierhaus A., Nawroth P.P. Insufficient glycemic control increases NF-κB binding activity in peripheral blood mononuclear cells isolated from patients with type I diabetes. Diabetes Care 1998; 21: 1–7
   PubMedGoogle Scholar
• Hoffmann M.A., Schiekofer S., Isermann B., Kanitz M., Henkels M., Joswig M., Treusch A., Morcos M., Weiss T., Borcea V., Abdel Khalek A.K.M., Amiral J., Tritschler H., Ritz E., Wahl P., Ziegler R., Bierhaus A., Nawroth P.P. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-κB. Diabetologia 1999; 42: 222–232
   PubMedGoogle Scholar
• Morigi M., Angioletti S., Imberti B., Donadelli R., Micheletti G., Figliuzzi M., Remuzzi A., Zoja C. Leukocyte-endothelial interaction is augmented by high glucose concentrations in a NF-κB-dependent fashion. J. Clin. Investig. 1998; 101: 1905–1915
   PubMed Web of Science ®Google Scholar
• Ceriello A., Falleti E., Motz E., Taboga C., Tonutti L., Ezsol Z., Gonano F., Bartoli E. Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm. Metab. Res. 1998; 30: 146–149
   PubMed Web of Science ®Google Scholar
• Schmidt A.M., Stern D.M. Hyperinsulinemia and vascular dysfunction. The role of Nuclear Factor-κB, yet again. Circ. Res. 2000; 87: 722–724
   PubMed Web of Science ®Google Scholar
• Lanfredini M., Fiorina P., Peca M.G., Veronelli A., Mello A., Astorri E., Dall'Aglio P., Craveri A. Fasting and post-methionine load homocys-t(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients. Metabolism 1998; 47: 915–927
   PubMedGoogle Scholar
• Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 1998; 338: 1042–1050
   PubMed Web of Science ®Google Scholar